Skip to main content

Table 6 Multivariate analysis of DFS, MFS, and OS of patients with early invasive ductal breast cancer

From: Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer

 

Variables

HR

95% CI

p

Disease-free survival

TRAIL-R3 in TEpC

3.566

1.164–10.920

0.026

Metastasis-free survival

Tumor size

8.210

2.013–33.477

0.003

CCR-2 in TEpC

10.257

2.569–40.947

0.001

Overall survival

TRAIL-R3 in TEpC

5.741

1.113–29.621

0.037

  1. C.I. confidence interval, HR hazard ratio